Where Jazz Pharmaceuticals Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided mostly bullish ratings for Jazz Pharmaceuticals (NASDAQ:JAZZ) in the last quarter, with an average price target of $202.62. This average price target has increased by 0.81% over the past month.

September 29, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have provided mostly bullish ratings for Jazz Pharmaceuticals, indicating a positive outlook for the stock.
The majority of analysts have given bullish ratings for Jazz Pharmaceuticals, which indicates a positive outlook for the stock. The average price target has also increased over the past month, suggesting that analysts expect the stock price to rise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100